CXCL12 and hepatocellular carcinoma: Moreover, silencing DDX5 in PRP19 knockdown HCC cells inhibited CXCL12 levels (FigureS7D,E, Supporting Information), B cell migration (Figure S7F, Supporting Information) and plasma cell differentiation (Figure S7G, Supporting Information).